![]() |
市場調查報告書
商品編碼
1930020
肢體義肢市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測(2026-2034)Limb Prosthetics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由於慢性疾病、創傷和血管疾病導致的截肢病例不斷增加,全球肢體義肢市場正經歷穩定成長。根據 Fortune Business Insights 預測,全球義肢市場規模預計在 2025 年達到 18.5 億美元,並在 2026 年達到 19.5 億美元。長期來看,該市場預計將進一步擴張,到 2034 年達到 30.9 億美元,2026 年至 2034 年的複合年增長率 (CAGR) 為 5.89%。
北美將在 2025 年佔義肢市場的主導地位,市佔率將達到 50.05%,這主要得益於美國和加拿大較高的肢體缺失率、先進義肢技術的早期應用、有利的報銷制度以及強勁的醫療保健支出。
市場概覽
義肢是用來取代缺失肢體、矯正身體畸形和恢復功能性活動能力的醫療器材。糖尿病、週邊血管疾病、癌症、感染和創傷的日益普遍導致全球截肢數量顯著增加,從而推動了對義肢解決方案的需求。在新冠疫情期間,由於患者就診量減少和手術延遲,市場出現萎縮,但自2021年以來,隨著常規醫療服務的恢復,市場呈現復甦趨勢。
正在進行的旨在開發先進義肢設計的臨床試驗和功能評估研究進一步增強了市場前景。持續的技術創新仍然是製造商和研究機構關注的重點領域。
新冠疫情的影響
2020年,新冠疫情對肢體義肢市場造成了負面影響,主要原因是醫師預約取消和擇期手術減少。在此期間,主要公司的收入均有所下降。然而,隨著限制措施的放鬆和患者就診量的增加,市場在2021年和2022年出現了復甦跡象。遠距醫療和數位技術的應用使多家義肢服務提供者得以繼續運營,從而促進了市場的穩定和逐步成長。
市場趨勢
影響市場發展的關鍵趨勢之一是肌電和腦電圖 (EEG) 控制義肢的研發。這些先進的設備能夠實現更自然的肢體運動,並改善患者的治療效果。製造商正日益關注機器人技術、神經介面和微處理器控制系統,以增強義肢的功能和使用者舒適度。預計這些技術進步將在預測期內推動義肢的普及。
成長因素
截肢數增加
創傷和慢性疾病導致的截肢數量不斷增加,仍然是市場成長的主要驅動因素。週邊血管疾病和糖尿病會顯著增加截肢的風險,尤其是在老年族群。涵蓋諮詢、安裝和設備更換的優惠報銷政策進一步促進了已開發地區肢體義肢的普及。
技術進步
動力膝關節、輕質材料和防水微處理器控制關節等先進技術的應用,正在改善截肢患者的行動能力和長期健康狀況。製造商正大力投資研發,推出滿足患者對舒適性、耐用性和功能性期望的創新產品。
限制因子
儘管需求強勁,但設備成本高昂仍是一項主要挑戰。先進的仿生和肌電義肢價格昂貴,限制了其普及程度,尤其是在報銷體系薄弱的新興經濟體。此外,部分地區訓練有素的義肢技師短缺也阻礙了市場擴張和普及。
按類型
此市場細分為上肢義肢和下肢義肢。
受下肢截肢率高且產品持續創新的推動,下肢義肢預計在2026年將佔市場佔有率的62.11%。預計上肢義肢的成長速度相對較慢。
依科技
依技術劃分,義肢分為傳統型、動力型和混合型。
由於價格實惠且普及性強,傳統型義肢預計在2026年將佔市場佔有率的45.10%。動力型義肢因其功能改進和有利的報銷政策而備受關注。
依最終使用者劃分
按最終用戶劃分,市場可分為矯形器和義肢 (O&P) 診所、骨科診所和其他機構。
到 2026 年,O&P 診所將佔市場主導地位,市佔率高達 87.37%,這主要得益於其專業服務、客製化能力和報銷優勢。
北美仍將是領先地區,到 2025 年市場規模將達到 9.3 億美元。
歐洲將佔第二大市場佔有率,這主要得益於其有利的報銷政策和積極的研發活動。
由於人口老化和糖尿病患者人數不斷增加,預計亞太地區將實現最快成長。
The global limb prosthetics market is experiencing steady growth due to the rising incidence of amputations caused by chronic diseases, trauma, and vascular disorders. According to Fortune Business Insights, the global limb prosthetics market was valued at USD 1.85 billion in 2025 and is projected to reach USD 1.95 billion in 2026. Over the long term, the market is expected to expand further and attain a value of USD 3.09 billion by 2034, registering a compound annual growth rate (CAGR) of 5.89% during the forecast period from 2026 to 2034.
North America dominated the limb prosthetics market with a 50.05% share in 2025, supported by a high prevalence of limb loss, early adoption of advanced prosthetic technologies, favorable reimbursement frameworks, and strong healthcare expenditure in the U.S. and Canada.
Market Overview
Limb prosthetics are medical devices prescribed to replace missing limbs, correct physical deformities, and restore functional mobility. The increasing prevalence of diabetes, peripheral vascular disease, cancer, infections, and traumatic injuries has significantly increased the global volume of amputations, thereby driving demand for prosthetic solutions. Although the market experienced a decline during the COVID-19 pandemic due to reduced patient visits and postponed procedures, recovery was observed from 2021 onward with the resumption of routine healthcare services.
Ongoing clinical trials and functional assessment studies aimed at developing advanced prosthetic designs are further strengthening the market outlook. Continuous innovation remains a key focus area for manufacturers and research institutions.
COVID-19 Impact
The COVID-19 pandemic negatively affected the limb prosthetics market in 2020, primarily due to appointment cancellations and reduced elective procedures. Major companies reported revenue declines during this period. However, recovery was observed in 2021 and 2022 as restrictions were lifted and patient visits increased. Adoption of teleconsultation and digital technologies enabled several prosthetic service providers to sustain operations, contributing to market stabilization and gradual growth.
Market Trends
One of the key trends shaping the market is the development of myoelectric and mind-controlled prostheses. These advanced devices enable more natural limb movement and improved patient outcomes. Manufacturers are increasingly focusing on robotics, neural interfaces, and microprocessor-controlled systems to enhance prosthetic functionality and user comfort. Such technological advancements are expected to increase adoption rates during the forecast period.
Growth Drivers
Rising Number of Amputations
The growing incidence of amputations due to traumatic injuries and chronic conditions remains the primary driver of market growth. Peripheral vascular disease and diabetes significantly increase the risk of limb loss, especially among elderly populations. Favorable reimbursement policies covering consultations, fittings, and device replacements further support the adoption of limb prosthetics in developed regions.
Technological Advancements
The incorporation of cutting-edge technologies, such as powered knees, lightweight materials, and waterproof microprocessor-controlled joints, is improving mobility and long-term health outcomes for amputees. Manufacturers are investing heavily in R&D to introduce innovative products that meet patient expectations for comfort, durability, and functionality.
Restraining Factors
Despite strong demand, high device costs remain a major challenge. Advanced bionic and myoelectric prostheses can be expensive, limiting affordability, particularly in emerging economies with weak reimbursement frameworks. Additionally, the shortage of trained prosthetists and orthotists in several regions restricts market expansion and accessibility.
By Type
The market is segmented into upper limb and lower limb prosthetics.
Lower limb prosthetics accounted for 62.11% of the market in 2026, driven by the high incidence of lower limb amputations and continuous product innovations. Upper limb prosthetics are expected to grow at a comparatively moderate pace.
By Technology
Based on technology, the market includes conventional, electric, and hybrid prosthetic devices.
Conventional prosthetic devices held a 45.10% share in 2026, owing to affordability and widespread availability. Electric prosthetics are gaining traction due to improved functionality and favorable reimbursement support.
By End User
By end user, the market is segmented into Orthotists & Prosthetists (O&P) clinics, orthopedic clinics, and others.
O&P clinics dominated the market with an 87.37% share in 2026, supported by specialized services, customization capabilities, and reimbursement advantages.
North America remains the leading region, with a market value of USD 0.93 billion in 2025.
Europe holds the second-largest share, driven by favorable reimbursement policies and strong R&D activity.
Asia Pacific is expected to grow at the fastest rate due to a rising elderly population and increasing prevalence of diabetes.
Competitive Landscape
Key players such as Ottobock and Ossur hold strong market positions due to diversified product portfolios, geographic reach, and continuous innovation. Other companies, including Blatchford, Steeper Inc., Hanger Inc., and Fillauer LLC, are expanding their presence through product launches, collaborations, and manufacturing expansion.
Conclusion
In conclusion, the global limb prosthetics market, valued at USD 1.85 billion in 2025, is projected to grow to USD 1.95 billion in 2026 and further reach USD 3.09 billion by 2034. Rising amputation rates, technological advancements, and favorable reimbursement policies will continue to support steady market growth during the forecast period.
Segmentation By Type, Technology, Component, End User, and Region
By Type * Upper Limb Prosthetics
By Technology * Conventional Prosthetic Devices
By Component * Socket
By End-user
Orthotists & Prosthetists (O&P) Clinics
By Region * North America (By Type, By Technology, By Component, By End User, and By Country)